André Planting

3.2k citations

71 papers · 2.6k indexed · h-index 31

Oncology top 2%
- Cancer Treatment and Pharmacology 17
- Lung Cancer Research Studies 16
- Colorectal Cancer Treatments and Studies 14
- Neutropenia and Cancer Infections 11
- Drug Transport and Resistance Mechanisms 5
Pulmonary and Respiratory Medicine top 5%
- Lung Cancer Treatments and Mutations 4
Toxicology top 5%
Molecular Biology top 10%
- Cancer therapeutics and mechanisms 24
Hepatology top 10%
Epidemiology
- Neuroendocrine Tumor Research Advances 5

Co-authors: Jaap Verweij G. Stoter Walter J. Loos Alex Sparreboom Ate van der Gaast Maja J.A. de Jonge Jan H.M. Schellens Chris Twelves
Cited by: Oncology Pulmonary and Respiratory Medicine Toxicology
Journals: Journal of Clinical Oncology (14 papers)European Journal of Cancer (11 papers)Annals of Oncology (10 papers)
Partner nations: Netherlands Belgium United States

In The Last Decade

André Planting

70 papers receiving 2.5k citations

Peers

Countries citing papers authored by André Planting

Since Specialization

Citations

This map shows the geographic impact of André Planting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Planting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Planting more than expected).

Fields of papers citing papers by André Planting

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Planting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Planting. The network helps show where André Planting may publish in the future.

Co-authorship network

The 25 scholars most cited alongside André Planting, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with André Planting Line = papers co-authored together André Planting links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A CYP3A4 Phenotype–Based Dosing Algorithm for Individualized Treatment of Irinotecan Clinical Cancer Research ·Jessica M. van der Bol,Ron H.J. Mathijssen,Geert-Jan Creemers,André Planting,Walter J. Loos,Erik A.C. Wiemer,Lena E. Friberg,Jaap Verweij,Alex Sparreboom,Floris A. de Jong	2010	50
2	Effects of methimazole on the elimination of irinotecan Cancer Chemotherapy and Pharmacology ·Jessica M. van der Bol,Theo J. Visser,Walter J. Loos,Floris A. de Jong,Erik A.C. Wiemer,Maarten O. van Aken,André Planting,Jan H.M. Schellens,Jaap Verweij,Ron H.J. Mathijssen	2010	6
3	Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors Molecular Cancer Therapeutics ·Richard D. Baird,Jos Kitzen,Paul A. Clarke,André Planting,Emmanel Essah,Alison Reid,Menghan Sun,Luis López Lázaro,Begoña de las Heras,Ian Judson,Stan B. Kaye,Ferry A.L.M. Eskens,Paul Workman,Johann S. de Bono,Jaap Verweij	2009	33
4	A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours British Journal of Cancer ·F. Eskens,Constantijne H. Mom,André Planting,Jourik A. Gietema,A. Amelsberg,Holger Huisman,Leni van Doorn,Henry Burger,Peter Stopfer,Jaap Verweij,Elisabeth G.E. de Vries	2007	202
5	A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumours Annals of Oncology ·裕康富田,Otto Soepenberg,Jaap Verweij,Maja J.A. de Jonge,André Planting,A. K. Shkvarok-Lisovenko,O. C. Кириченко,R. Obach,Chris Twelves	2007	17
6	Phase I and Pharmacokinetic Study of the Polyamine Synthesis Inhibitor SAM486A in Combination with 5-Fluorouracil/ Leucovorin in Metastatic Colorectal Cancer Clinical Cancer Research ·Lia van Zuylen,John Bridgewater,Alex Sparreboom,Ferry A.L.M. Eskens,Peter de Bruijn,I. Sklenar,André Planting,Uly Fithria Ghani,Douglas Bootle,Christian Mueller,Jonathan A. Ledermann,Jaap Verweij	2004	16
7	Phase I study of concomitant chemoradiation with raltitrexed in locally advanced head and neck cancer European Journal of Cancer ·André Planting,Maja J.A. de Jonge,Peter P. Jansen,Jeroen D. F. Kerrebijn,昶鈴木,Lorna Sarahi López Díaz	2004	11
8	A phase I and pharmacologic study of the matrix metalloproteinase inhibitor CP-471,358 in patients with advanced solid tumors Cancer Chemotherapy and Pharmacology ·André Planting,Ate van der Gaast,Patrick Schöffski,Р. В. Власов,C D G W Verheij,Dennis A. Noe,Karen J. Ferrante,Jaap Verweij	2004	7
9	Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancer Annals of Oncology ·C.M.F. Kruijtzer,Henk Boot,Jos H. Beijnen,بشائر هادي حسن رزج,Francis Parnis,André Planting,Mosquera Anzules,R. Williams,Ron A. A. Mathôt,Hilde Rosing,Margaret Schot,Harm van Tinteren,Jan H.M. Schellens	2003	37
10	Adaptive intrapatient dose escalation of cisplatin in combination with low-dose vp16 in patients with nonsmall cell lung cancer British Journal of Cancer ·Jan H.M. Schellens,André Planting,Nico van Zandwijk,Jun Ma,Marc Maliepaard,M.E.L. van der Burg,M de Boer-Dennert,E. Brouwer,Ate van der Gaast,Martin J. van den Bent,Jaap Verweij	2003	11
11	Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer. Journal of Clinical Oncology ·Melanie Mackean,André Planting,Chris Twelves,J. Schellens,David Allman,B Osterwalder,Bruno Reigner,T. Griffin,S.B. Kaye,Jaap Verweij	1998	224
12	Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors. Journal of Clinical Oncology ·G.J. Creemers,C J Gerrits,John R. Eckardt,Jan H.M. Schellens,Howard A. Burris,André Planting,G I Rodriguez,Walter J. Loos,I Hudson,Colin Broom,Jaap Verweij,Daniel D. Von Hoff	1997	66
13	The value of immunohistochemistry in patients with poorly differentiated adenocarcinomas and undifferentiated carcinomas of unknown primary Journal of Cancer Research and Clinical Oncology ·Ate van der Gaast,Jaap Verweij,André Planting,G. Stoter,S.C. Henzen‐Logmans	1996	12
14	Local Tumor Control in Radiation Therapy of Cancers in the Head and Neck American Journal of Clinical Oncology ·Peter C. Levendag,Peter J.C.M. Nowak,Maurice J.C. van der Sangen,Peter P. Jansen,Wilhelmina M.H. Eijkenboom,André Planting,Cees A. Meeuwis,Wim L.J. van Putten	1996	22
15	Phase I study of weekly high-dose cisplatin combined with long-term oral etoposide in advanced solid tumors Annals of Oncology ·André Planting,M E van der Burg,M de Boer-Dennert,G. Stoter,Jaap Verweij	1995	16
16	Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in pleural mesothelioma Annals of Oncology ·André Planting,Songul Comert Kilic,S.H. Goey,Сеферян Артур Ефремович,Martin J. van den Bent,M de Boer-Dennert,G. Stoter,Jaap Verweij	1995	34
17	Clinical course and risk factors of neurotoxicity following cisplatin in an intensive dosing schedule European Journal of Neurology ·P.H.E. Hilkens,André Planting,M.E.L. van der Burg,J. Moll,Wim L.J. van Putten,Ch.J. Vecht,Martin J. van den Bent	1994	11
18	Phase II study of oral administration of etoposide for patients with well- and moderately-differentiated adenocarcinomas of unknown primary site Annals of Oncology ·Ate van der Gaast,S.C. Henzen‐Logmans,André Planting,G. Stoter,Jaap Verweij	1993	5
19	Phase II study of cisplatin plus 24-hour infusion of ifosfamide in advanced malignant melanoma Annals of Oncology ·Jaap Verweij,André Planting,Adriana Neligan,G. Stoter	1990	8
20	Two carboplatin-containing regimens for small cell lung cancer: preliminary results of a randomized phase II trial Cancer Treatment Reviews ·Pieter E. Postmus,A. Kirkpatrick,Otilia Dalesio,W. de Vos,D N Carney,Jan Festen,C. P. J. Vendrik,K. J. Roozendaal,J Burghouts,André Planting,(unknown),(unknown),(unknown)	1988	8

About André Planting

André Planting is a scholar working on Oncology, Otorhinolaryngology and Cancer Research, having authored 71 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (24 papers), Cancer Treatment and Pharmacology (17 papers), Lung Cancer Research Studies (16 papers), Colorectal Cancer Treatments and Studies (14 papers), Neutropenia and Cancer Infections (11 papers), Neuroendocrine Tumor Research Advances (5 papers), Drug Transport and Resistance Mechanisms (5 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Oncology (1.6k citations), Pulmonary and Respiratory Medicine (720 citations) and Toxicology (64 citations). André Planting has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Jaap Verweij, G. Stoter, Walter J. Loos, Alex Sparreboom, Ate van der Gaast, Maja J.A. de Jonge, Jan H.M. Schellens, Chris Twelves, Bruno Reigner and B Osterwalder. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, Clinical Cancer Research and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact